Enzo Biochem Azione

Enzo Biochem Debiti verso fornitori

Delisted·17 apr 2025

Il Debiti Commerciali di Enzo Biochem (ENZ) al 17 ago 2026 è 1,38 Mio. USD. L'anno precedente, Debiti Commerciali era 3,58 Mio. USD — una variazione del -61,51% (inferiore).

Debiti verso fornitori

1,38 Mio.USD

YoY

-61,51%

Ultimo aggiornamento:

Debiti Commerciali di Enzo Biochem ammonta a 2026 1,38 Mio. USD. Debiti Commerciali di Enzo Biochem ammontava a 2025 3,58 Mio. USD. Diminuisce del -61,51% inferiore rispetto all'anno precedente.
Access this data via the Eulerpool API

Enzo Biochem Analisi delle Azioni

Cosa fa Enzo Biochem? Enzo Biochem Inc is a US-based company operating in the biotechnology sector. It was founded in 1976 by Elazar Rabbani and is headquartered in New York. The company focuses on developing, producing, and marketing innovative diagnostic and therapeutic products for the medical industry. Enzo Biochem Inc's business model is based on the application of modern technologies for the development and synthesis of molecules for medical technology and life sciences. At the same time, the company also offers diagnostic testing systems and clinical laboratory services to its customers. Enzo Biochem's business model is therefore diverse and covers various areas. Enzo Biochem divides its business into three main segments: life sciences, clinical labs, and therapeutics. In the life sciences segment, the company engages in research and development of technologies for synthesizing molecules for medical technology. In the clinical labs segment, Enzo Biochem offers diagnostic testing systems and clinical laboratory services for use in medical diagnostics. The therapeutics segment manufactures therapeutic products for the treatment of viral infections. Enzo Biochem's product offering includes a wide range of products and services. This includes molecules for medical technology, diagnostic testing systems, and therapy products for viral infections. The product lines of Enzo Biochem include: - Molecules for medical technology: Enzo Biochem has developed a wide range of molecules for medical technology and is a leader in this field. These molecules include proteins, antibodies, and other biomolecules. The company also offers custom molecules for specific applications. - Diagnostic testing systems: The company offers a wide range of diagnostic testing systems tailored to the needs of laboratories and clinics. The tests include tests for infectious diseases, cancer, metabolic disorders, and other diseases. - Clinical laboratory services: Enzo Biochem provides a wide range of clinical laboratory services, including blood tests, microbiological tests, urine, stool, and body fluid tests, as well as histological analysis of tissue samples. - Therapy products: Enzo Biochem has developed a broad portfolio of therapy products for the treatment of viral infections. These products include immunomodulators, antivirals, and other therapeutics aimed at combating various pathogens. Enzo Biochem has made a name for itself in the biotechnology industry through continuous innovation and high-quality products. The company has also engaged in partnerships, acquisitions, and joint ventures to expand its global footprint. It has a global presence and works with leading pharmaceutical and biotech companies from around the world. Overall, Enzo Biochem has established itself as a leading biotechnology company operating in the fields of life sciences, clinical labs, and therapeutics. The company offers a wide range of products and services tailored to the needs of laboratories and clinics. Enzo Biochem has established itself as an innovation leader in the biotechnology industry and is committed to further expanding its business through the development of new products and technologies. Enzo Biochem è una delle aziende più popolari su Eulerpool.com.

Domande frequenti su Enzo Biochem azioni

Debiti Commerciali di Enzo Biochem è 1,38 Mio. USD nel 2026.

Il Debiti Commerciali di Enzo Biochem è passato da 3,58 Mio. USD a 1,38 Mio. USD, con una variazione del -61,51 %. Il valore è inferiore rispetto all'anno precedente.

Su Eulerpool è possibile consultare lo sviluppo storico completo del Enzo Biochem di Debiti Commerciali dal 2006, con valori annuali, grafici e analisi dettagliate.

I debiti commerciali rappresentano il denaro dovuto ai fornitori per beni e servizi ricevuti. È un componente fondamentale della gestione del capitale di esercizio.

Il USD di Debiti Commerciali è un fattore chiave per gli investitori. I cambiamenti in questa metrica possono segnalare il miglioramento o il deterioramento dei fondamentali, impattando direttamente il prezzo delle azioni. Su Eulerpool puoi tracciare il Enzo Biochem di Debiti Commerciali storicamente e in tempo reale.

Access this data via the Eulerpool API

Bilancio — Enzo Biochem

Tutte le Metriche Finanziarie — Enzo Biochem